Last update :
19/11/2024
Antimuscarinic   Glycopyrronium bromide  
Oral solution
injection
Stability of pharmaceutical preparations Stability of mixtures Factors which affect stability Compatibility References pdf
   Chemical structure  

Oral solution
Stability of pharmaceutical preparations   Oral solution   Stability of pharmaceutical preparations : Glycopyrronium bromide     
Container Origine excipient Temperature Storage Duration of stability References
Glass tablets 50 mg
®=? Horizon pharmaceutical
Tap water 100 ml
24-26°C Protect from light
25 Day
2833

Glass powder 10 mg
® = ?
SyrSpend SF® >> 20 ml
25°C Not specified
90 Day
4198

Glass powder 10 mg
® = ?
SyrSpend SF® >> 20 ml
4°C Not specified
90 Day
4198

plastic bottle tablets 30 mg
® = ? (Corepharma)
OraPlus® / OraSweet® (1:1) >> 60 ml
23-25°C Protect from light
90 Day
3203

plastic bottle tablets 30 mg
® = ? (Corepharma)
OraPlus® / OraSweet SF® (1:1) >> 60 ml
23-25°C Protect from light
90 Day
3203

plastic bottle tablets 20 mg
® = ?
OraPlus® / OraSweet® (1:1) >> 100 ml
25°C Protect from light
14 Day
3856

plastic bottle tablets 20 mg
® = ?
Methylcellulose 1% / Simple syrup (1:10) >> 100 ml
25°C Protect from light
14 Day
3856

plastic bottle tablets 20 mg
® = ?
OraPlus® / OraSweet® (1:1) >> 100 ml
4°C Protect from light
14 Day
3856

plastic bottle tablets 20 mg
® = ?
Methylcellulose 1% / Simple syrup (1:10) >> 100 ml
4°C Protect from light
14 Day
3856

Not specified powder 50 mg
Sorbitol 10 g
phosphate buffer 0.05M pH 5.6 >> 100 ml
24-26°C Protect from light
129 Day
2834

Not specified powder 50 mg
Sucrose 10 g
phosphate buffer 0.05M pH 5.6 >> 100 ml
24-26°C Protect from light
129 Day
2834


  Mentions Légales